Evidence map›Paper›PMID 36111517›Full record

ArticleESC heart failure2022

Characteristics and long-term survival of patients with left ventricular non-compaction cardiomyopathy.

Emre Demir, Selen Bayraktaroğlu, Akın Çinkooğlu, Aytaç Candemir, Yeşim B Candemir, Rıza O Öztürk, Ömer F Dadaş, Mehmet N Orman, Mehdi Zoghi, Azem Akıllı and 3 more

Open access · goldAbstract read
In one paragraph

Article in ESC heart failure, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Emre DemirDepartment of Cardiology, Ege University School of Medicine, Bornova, Turkey.ORCID 0000-0001-7552-8967
Selen BayraktaroğluDepartment of Radiology, Ege University School of Medicine, Bornova, Turkey.
Akın ÇinkooğluDepartment of Radiology, Ege University School of Medicine, Bornova, Turkey.
Aytaç CandemirDepartment of Cardiology, Ege University School of Medicine, Bornova, Turkey.
Yeşim B CandemirDepartment of Cardiology, Ege University School of Medicine, Bornova, Turkey.
Rıza O ÖztürkDepartment of Cardiology, Ege University School of Medicine, Bornova, Turkey.
Ömer F DadaşDepartment of Biostatistics and Bionformatics, Ege University School of Medicine, Bornova, Turkey.
Mehmet N OrmanDepartment of Biostatistics and Bionformatics, Ege University School of Medicine, Bornova, Turkey.
Mehdi ZoghiDepartment of Cardiology, Ege University School of Medicine, Bornova, Turkey.
Azem AkıllıDepartment of Cardiology, Ege University School of Medicine, Bornova, Turkey.
Naim CeylanDepartment of Radiology, Ege University School of Medicine, Bornova, Turkey.
Cemil GürgünDepartment of Cardiology, Ege University School of Medicine, Bornova, Turkey.
Sanem NalbantgilDepartment of Cardiology, Ege University School of Medicine, Bornova, Turkey.
Ege University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsLeft ventricular non-compaction cardiomyopathy (LVNC) is a poorly understood entity resulting in heart failure. Whether it is a distinct form of cardiomyopathy or an anatomical phenotype is a subject of discussion. The current diagnosis is based on morphologic findings by comparing the compacted to non-compacted myocardium. The study aimed to compare demographic and prognostic variables of patients with dilated cardiomyopathy (DCM) and LVNC. Emphasis was given to cardiac magnetic resonance (CMR) imaging analysis. Data on survival were also assessed. METHODS AND

resultsWe retrospectively evaluated the characteristics and outcomes of 262 non-ischaemic cardiomyopathy patients with LVNC and DCM phenotypes. Petersen's CMR criteria of non-compacted to the compacted myocardial ratio 2.3 were used to diagnose LVNC. The primary endpoint was a composite endpoint of major adverse cardiovascular events comprising cardiovascular-related death, left ventricular assisted device implantation, or heart transplantation. A total of 262 patients with CMR data were included in the study. One hundred fifty-five patients who fulfilled CMR criteria were diagnosed as LVNC. CMR findings revealed that LVNC patients had higher left ventricular end-diastolic (137.2 ± 51.6, 116.8 ± 44.6, P = 0.002) and systolic volume index (98.4 ± 49.5, 85.9 ± 42.7, P = 0.049). Cardiac haemodynamics, cardiac output (5.61 ± 2.03, 4.96 ± 1.83; P = 0.010), stroke volume (73.9 ± 28.8, 65.1 ± 25.1; P = 0.013), and cardiac index (2.85 ± 1.0, 2.37 ± 0.72; P < 0.0001), were higher in LVNC patients. Of all the 249 patients, 102 (40.9%) patients demonstrated late gadolinium enhancement (LGE). According to Petersen's criteria, the Kaplan-Meier survival outcome did not reveal significant differences (hazard ratio [HR]: 1.53, 95% confidence interval [CI]: [0.89-2.63], P = 0.11). The presence or pattern of LGE did not show significant importance for endpoint-free survival. Most of the sub-epicardial LGE pattern was found in LVNC patients (94.4%). When receiver operator characteristics analysis was applied to NC/C ratio to discriminate the primary endpoint, a higher NC/C ratio of 2.57 was associated with adverse events (HR: 1.90, 95% CI: [1.12-3.24], P = 0.016).

conclusionsOur study questions the criteria being used for the diagnosis of LVNC. Further evaluation of CMR variables and association of these findings with demographic variables and survival is mandatory.

Indexed as

CardiomyopathiesCardiomyopathy, DilatedContrast MediaGadoliniumHumansPredictive Value of TestsRetrospective StudiesVentricular Function, LeftContrast MediaGadoliniumCardiac magnetic resonance imagingDilated cardiomyopathyLate gadolinium enhancementLeft ventricular non-compaction cardiomyopathy

Identifiers

PMID36111517
PMCPMC9773712
OpenAlexW4296032567

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.